Avalyn Pharma Inc. (AVLN)

NASDAQ

$23.65

$+0.24

(+1.02%)

Pre-Market

Avalyn Pharma Inc. (AVLN) Live Price Chart

Last updated: ⁦2026-10-20 09:39:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Avalyn Pharma Inc. (AVLN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $23.65, with a market capitalization of $1.05B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $22.68 to $40.17. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.05B
Open	$23.41
Day's High	$40.17
Day's Low	$22.68
Previous Close	$23.33
Volume	36.00
Average Volume	241.90K
P/E Ratio	--
52-Week High	$40.17
52-Week Low	$22.68
Dividend Yield	--
Earnings Date	--

Avalyn Pharma Inc. (AVLN) Pre-Market Stock Price

Avalyn Pharma Inc. (AVLN) is trading at $23.65 in pre-market trading as of 2026-10-20 08:26:00, up 1.37% ($0.32) from the previous close of $23.33

Pre-market trading shows how investors are pricing AVLN before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Avalyn Pharma Inc. (AVLN) 7-Day Stock Price Change

Over the past seven days, Avalyn Pharma Inc. (AVLN) moved from $25.76 to $23.65, representing a decline of 8.19% ($2.11).

The stock traded between $22.68 and $30.00 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 245.38 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

AVLN 52-Week Price Position

Position in Range: 5.5%

52W Low$22.68

52W High$40.17

AVLN is currently trading at $23.65, placing it 5.5% of the way from its 52-week low of $22.68 to its 52-week high of $40.17. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Avalyn Pharma Inc. (AVLN)?

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

Avalyn Pharma Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.avalynpharma.com

How to Buy Avalyn Pharma Inc. (AVLN) Stock on MEXC

Eligible investors can buy real shares of Avalyn Pharma Inc. (AVLN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AVLN and Place Your Order

Open the RealStocks trading page and search for AVLN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Avalyn Pharma Inc. (AVLN) stock price today?

Avalyn Pharma Inc. (AVLN) is currently trading at $ 23.65, up 1.37% ($0.32) from the previous close of $ 23.33. Intraday prices update in real time during regular trading hours.

2.Is AVLN stock going up or down today?

As of 2026-10-20 08:26:00, AVLN is trading at $ 23.65, up 1.37% ($0.32) from its previous close of $ 23.33. The stock has traded between $ 22.68 and $ 40.17 during today’s regular session. Past price movements do not guarantee future results.

3.What is AVLN pre-market price?

As of 2026-10-20 08:26:00, AVLN is trading at $ 23.65 in pre-market trading, up 1.37% ($0.32) from the previous close of $ 23.33. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AVLN after-hours price?

As of 2026-10-20 08:26:00, AVLN is trading at $ 23.41 in after-hours trading, up 0.33% ($0.08) from the regular-session close of $ 23.33. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AVLN stock trading now?

AVLN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AVLN sit relative to its 52-week high and low?

Over the past 52 weeks, AVLN has traded between a low of $ 22.68 and a high of $ 40.17. At $ 23.65, the stock is positioned 5.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Avalyn Pharma Inc. in?

Avalyn Pharma Inc. (AVLN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Avalyn Pharma Inc.'s market capitalization and where is it listed?

Avalyn Pharma Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.05B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AVLN valued in terms of P/E ratio and EPS?

AVLN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Avalyn Pharma Inc. pay a dividend?

Avalyn Pharma Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.